David Thomas Evans - 12 Jan 2026 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role: Chief Financial Officer
Signature: /s/ Nick Lynton, Attorney-in-Fact
Issuer symbol: CDLX
Transactions as of: 12 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 16 Jan 2026, 16:46:07 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Evans David Thomas	Chief Financial Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 4100, ATLANTA	/s/ Nick Lynton, Attorney-in-Fact	16 Jan 2026	0001730451

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDLX	Restricted Stock Units	Award	$0	+1,000,000		$0.000000	1,000,000	12 Jan 2026	Common Stock	1,000,000		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	50% of the shares underlying the RSU award will vest on February 1, 2027, with the remaining 50% vesting in equal amounts quarterly over a one-year period through February 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates.